Summary In 28 patients with neuroblastoma of different stages the karyotype was determined in the primary tumour and/or in the metastases by direct chromosome preparation or short term cell culture. In addition, DNA analysis for the proto-oncogene N-myc was performed for comparison in 10 cases.
After brain tumours neuroblastoma represents the most common solid tumour in childhood with an annual incidence of 8 cases per million children under 15 years; most of them -in contrast to the more frequent childhood leukaemiasoccurring within the first 3 years of life.
The biological behaviour of neuroblastoma is unique and still puzzling to paediatric oncologists in that there is spontaneous regression in congenital tumours (even in the metastatic stage) and an almost 100% survival rate in localized tumours as compared to a less than 10% survival chance in non-localized, disseminated tumours in children over 1 year of age in spite of intensive chemotherapy (Berthold et al., 1986) . Besides known prognostic factors such as age and tumour stage additional clinical factors useful in predicting outcome, such as serum ferritin and histologic type, have recently been emphasized (Evans et al., 1987) . Also, the DNA properties of neuroblastoma cells such as the increased copy number of the proto-oncogene N-myc (Brodeur et al., 1984; Seeger et al., 1985) or the increased expression of the oncogene (Rosen et al., 1986) were found to be associated with progressive growth of the tumour.
That tumour karyotype may be important in the prognosis of human neuroblastoma was proposed by us after we obtained tumour cytogenetic data in a series of 14 children with neuroblastoma (Franke et al., 1986a) . In an extended series of 28 patients with all the different tumour stages we now confirm the presence or absence of the chromosome 1 short arm abnormality as the most decisive factor characterizing the different biological behaviour of neuroblastoma cell clones and thus the clinical outcome.
Materials and methods
Patients were registered and prospectively treated within the consecutive Neuroblastoma Trials NB 79, NB 82, and NB 85 of the German Paediatric Oncology Group which allowed uniform treatment, documentation, pathological evaluation, and continuous control of all clinical parameters (Berthold et al., 1986 (Franke et al., 1986b) . Chromosome preparations of bone marrow metastases were performed after cell synchronisation with methotrexate. Chromosomes were Gbanded with 3% Giemsa solution (pH 6.8) after pretreatment with trypsin. The best banded metaphases were photographed and karyotyped. In the majority of the patients more than 20 tumour metaphases could be analyzed.
DNA analysis of the N-myc gene from the same tumour cell material that was used for chromosome study could be performed in 10 patients. Isolated DNA was digested with EcoRI, electrophoresed, and transferred on to filter membranes (Du Pont) . N-myc amplification was tested with the blotting method (Southern) using the probe NB-1 (Schwab et al., 1983) which detects 2.0Kb EcoRI fragments.
The extent of N-myc amplification was confirmed by dotblot analyses via serial dilution of the tumour-DNA.
Results
Chromosomes could be successfully prepared and analyzed from neuroblastoma tissue in 28 patients out of a total of about 90 patients examined.
The clinical and the most important cytogenetic data such as the lp abnormality, DMs and HSRs, including N-myc copies in the tumour where DNA analysis was performed, are summarized in Table I . In Table II 6, 11, 12, 17 (long arm).
As to localization of the breakpoint in the abnormal lp tumour chromosome, 12 patients could be precisely analyzed, and 1p32 was found to be the most frequently involved (Figure 3) . The correlation of karyotypic patterntaking the lp abnormality as the most characteristic chromosome aberration -with survival could be demon- (Christiansen et al., 1987) , multiple copies of N-myc would be present in about 60% of patients with stage IV. As a chromosome lp abnormality is encountered more frequently in this stage of progressive tumour growth one might speculate that the aberration of chromosome 1 distal to band lp22 (Brodeur et al., 1981; Gilbert et al., 1984) or lpl3 (our results) is the primary event, and gene amplification is secondary, being rarely associated with morphologic uniformity. As shown by our analysis, HSRs were distributed among several chromosomes and different arms, involving the short arm of chromosomes 4 and 15 and the long arms of chromosomes 6, 9, 11, 19 and 20, and, interestingly, DMs were found in two different size groups in a case of metastatic neuroblastoma (Franke, et al., 1985) .
If one takes deletion of certain genes on the short arm of one chromosome 1 as the crucial primary event for aggressive growth in neuroblastomas, our life table analysis can clearly distinguish two groups of patients -regardless of stage and age -one with a less than 10% survival chance versus the other with a 90% survival probability. This is superior to N-myc oncogene determinations in that 55 patients with only a single copy of the gene in their tumour DNA had an estimated survival rate of less than 60% (Seeger et al., 1985) .
Neuroblastoma cells with undisturbed homologues of chromosome 1 -probably a completely different entitymight just be temporarily deregulated or because of increased DNA content more vulnerable to chemotherapy.
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